The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - GlaxoSmithKline; Pfizer; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Travel, Accommodations, Expenses - Pfizer
Predictors for survival with cabazitaxel (CBZ) in metastatic, castration-resistant prostate cancer (mCRPC): Long term follow-up of the Spanish registry.
 
Iria González-Maeso
No Relationships to Disclose
 
Nuria Lainez
No Relationships to Disclose
 
Daniel Castellano
No Relationships to Disclose
 
Iciar Garcia Carbonero
No Relationships to Disclose
 
Pablo Borrega
No Relationships to Disclose
 
Begona Campos Balea
No Relationships to Disclose
 
Rosa Garcia Marrero
No Relationships to Disclose
 
Emilio Esteban
No Relationships to Disclose
 
Alejo Rodriguez Vida
No Relationships to Disclose
 
Javier Munarriz
No Relationships to Disclose
 
Jose Maria Garcia-Bueno
No Relationships to Disclose
 
Maria L. Villalobos
No Relationships to Disclose
 
Ruth Viciana
No Relationships to Disclose
 
Gustavo Rubio
No Relationships to Disclose
 
Begoña Perez-Valderrama
No Relationships to Disclose
 
Jose Garcia Sanchez
No Relationships to Disclose
 
Beatriz Pelaez Lorenzo
No Relationships to Disclose
 
Jose David Cumplido Buron
No Relationships to Disclose
 
Almudena Martin
No Relationships to Disclose
 
Joaquim Bellmunt
Consulting or Advisory Role - Astellas Pharma; Genentech; Merck; Novartis; Pfizer; Pierre Fabre
Research Funding - Millennium (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Pfizer